PLOS Medicine | www.plosmedicine.org
January 2013 | Volume 10 | Issue 1 | e1001371
A planner’s guide to proposal development for national school-based deworming programs
Revision for Field Review
Online version of the manual: https://iawgfieldmanual.com/manual
July 2019
National Malaria Elimination & Aedes Transmitted Disease Control Program
Disease Control Division
Derectorate General of Health Services
Lancet 2013; 381: 1405–16
Series: Childhood Pneumonia and Diarrhoea no.1
Document also available in English, Chinese, Greek, Italian, Korean and Vietnamese. For other language versions go to http://www.schn.health.nsw.gov.au/parents-and-carers/fact-sheets/fever
Towards a world free of tuberculosis
El Grupo de Trabajo para la Protección de la Infancia define a la protección de la infancia como “la prevención y la respuesta al abuso, negligencia, explotación y violencia contra los niños, niñas y adolescentes”. Complemento al Manual Esfera.
Three billion people – 40 per cent of the world’s population – do not have a place in their homes to wash their hands with water and soap. Three quarters of those who lack access to water and soap live in the world’s poorest countries and are amongst the most vulnerable: children and familie...s living in informal settlements, migrant and refugee camps, or in areas of active conflict. This puts an estimated 1 billion people at immediate risk of COVID-19 simply because they lack basic handwashing facilities.
The Hand Hygiene for All initiative aims to move the world towards this goal: supporting the most vulnerable communities with the means to protect their health and environment. It brings together international partners, national governments, public and private sectors, and civil society to ensure affordable products and services are available, especially in disadvantaged areas, and to enable a culture of hygiene.
more
Ministry of Health & Family Welfare
28.03.2020
हाथ धोने के सामान्य नियमों का पालन करके ही हम #COVID19 को समाप्त कर सकते हैं। जानिए कैसे।
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58